Clinical Trial Update: An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating ICP-192 for efficacy and safety in bladder urothelial cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Bladder Urothelial Cancer

Drugs mentioned

• ICP-192

Snippet

Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. | Conditions: Bladder Urothelial Cancer | Phase 2 | Status: UNKNOWN